The role of hyperbaric oxygen therapy in the treatment of radiation lesions.
Cystitis
Hyperbaric oxygen therapy
Osteoradionecrosis
Proctitis
Radiation induced
Journal
Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
ISSN: 1699-3055
Titre abrégé: Clin Transl Oncol
Pays: Italy
ID NLM: 101247119
Informations de publication
Date de publication:
Dec 2022
Dec 2022
Historique:
received:
04
04
2022
accepted:
14
07
2022
pubmed:
18
8
2022
medline:
19
10
2022
entrez:
17
8
2022
Statut:
ppublish
Résumé
Cancer remains one of the leading causes of death worldwide, with 50-60% of patients requiring radiotherapy during the course of treatment. Patients' survival rate has increased significantly, with an inevitable increase in the number of patients experiencing side effects from cancer therapy. One such effect is late radiation injuries in which hyperbaric oxygen therapy appears as complementary treatment. With this work we intend to divulge the results of applying hyperbaric oxygen therapy among patients presenting radiation lesions in our Hyperbaric Medicine Unit. Retrospective analysis of clinical records of patients with radiation lesions treated at the Hyperbaric Medicine Unit assessed by the scale Late Effects of Normal Tissues-Subjective, Objective, Management, Analytical (LENT-SOMA) before and after treatment, between October 2014 and September 2019 were included. Demographic characteristics, primary tumor site, subjective assessment of the LENT-SOMA scale before and after treatment were collected and a comparative analysis (Students t test) was done. 88 patients included: 33 with radiation cystitis, 20 with radiation proctitis, 13 with osteoradionecrosis of the mandible and 22 with radiation enteritis. In all groups, there was a significant decrease (p < 0.005) in the subjective parameter of the LENT-SOMA scale. Late radiation lesions have a major influence on patients' quality of life. In our study hyperbaric oxygen therapy presents as an effective therapy after the failure of conventional treatments. Hyperbaric oxygen therapy is an effective complementary therapy in the treatment of refractory radiation lesions.
Identifiants
pubmed: 35976581
doi: 10.1007/s12094-022-02892-x
pii: 10.1007/s12094-022-02892-x
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
2466-2474Informations de copyright
© 2022. The Author(s), under exclusive licence to Federación de Sociedades Españolas de Oncología (FESEO).
Références
Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424. https://doi.org/10.3322/caac.21492 .
doi: 10.3322/caac.21492
pubmed: 30207593
WHO, Portugal Population Fact Sheets, In: The Globo Cancer Observatory. 2021. https://gco.iarc.fr/today/data/factsheets/populations/620-portugal-fact-sheets.pdf . Accessed 27 July 2022.
Borras JM, Lievens Y, Barton M, Corral J, Ferlay J, Bray F, Grau C. How many new cancer patients in Europe will require radiotherapy by 2025? An ESTRO-HERO analysis Radiother Oncol. 2016;119(1):5–11. https://doi.org/10.1016/j.radonc.2016.02.016 .
doi: 10.1016/j.radonc.2016.02.016
pubmed: 26922487
Yucel B, Akkaş EA, Okur Y, Eren AA, Eren MF, Karapinar H, Babacan NA, Kiliçkap S. The impact of radiotherapy on quality of life for cancer patients: a longitudinal study. Support Care Cancer. 2014;22(9):2479–87. https://doi.org/10.1007/s00520-014-2235-y .
doi: 10.1007/s00520-014-2235-y
pubmed: 24728584
Joiner MC, van der Kogel A. Basic clinical radiobiology. 4th ed. CRC Press; 2009. https://doi.org/10.1201/b15450 .
doi: 10.1201/b15450
Halperin EC, Wazer DE, Perez CA, Brady LW. Perez & Brady’s principles and practice of radiation oncology. 7th ed. Wolters Kluwer Health; 2019.
Szumiel I. Intrinsic radiation sensitivity: cellular signaling is the key. Radiat Res. 2008;169(3):249–58. https://doi.org/10.1667/RR1239.1 .
doi: 10.1667/RR1239.1
pubmed: 18302493
Gunderson T. Clinical radiation oncology. 3rd ed. Philadelphia: Elsevier; 2012.
Dearnaley D, Syndikus I, Mossop H, Khoo V, Birtle A, Bloomfield D, Graham J, Kirkbride P, Logue J, Malik Z, Money-Kyrle J, O’Sullivan JM, Panades M, Parker C, Patterson H, Scrase C, Staffurth J, Stockdale A, Tremlett J, Bidmead M, Mayles H, Naismith O, South C, Gao A, Cruickshank C, Hassan S, Pugh J, Griffin C, Hall E, CHHiP Investigators. Conventional versus hypofractionated high-dose intensity-modulated radiotherapy for prostate cancer: 5-year outcomes of the randomised, non-inferiority, phase 3 CHHiP trial. Lancet Oncol. 2016;17(8):1047–60. https://doi.org/10.1016/S1470-2045(16)30102-4 .
doi: 10.1016/S1470-2045(16)30102-4
pubmed: 27339115
pmcid: 4961874
Catton CN, Lukka H, Julian JA, Gu C-S, Martin J, Supiot S, Chung PWM, Bauman G, Bahary J-P, Ahmed S, Cheung P, Tai KH, Wu J, Parliament M, Levine MN. A randomized trial of a shorter radiation fractionation schedule for the treatment of localized prostate cancer. J Clin Oncol. 2016;34(15):5003. https://doi.org/10.1200/JCO.2016.34.15_suppl.5003 .
doi: 10.1200/JCO.2016.34.15_suppl.5003
Incrocci L, Wortel RC, Alemayehu WG, Aluwini S, Schimmel E, Krol S, van der Toorn PP, Jager H, Heemsbergen W, Heijmen B, Pos F. Hypofractionated versus conventionally fractionated radiotherapy for patients with localised prostate cancer (HYPRO): final efficacy results from a randomised, multicentre, open-label, phase 3 trial. Lancet Oncol. 2016;17(8):1061–9. https://doi.org/10.1016/S1470-2045(16)30070-5 .
doi: 10.1016/S1470-2045(16)30070-5
pubmed: 27339116
Morgan SC, Hoffman K, Loblaw DA, Buyyounouski MK, Patton C, Barocas D, Bentzen S, Chang M, Efstathiou J, Greany P, Halvorsen P, Koontz BF, Lawton C, Leyrer CM, Lin D, Ray M, Sandler H. Hypofractionated radiation therapy for localized prostate cancer: executive summary of an ASTRO, ASCO and AUA evidence-based guideline. J Urol. 2019;201(3):528–34. https://doi.org/10.1097/JU.0000000000000071 .
doi: 10.1097/JU.0000000000000071
pubmed: 30759696
Haviland JS, Owen JR, Dewar JA, et al. The UK Standardisation of Breast Radiotherapy (START) trials of radiotherapy hypofractionation for treatment of early breast cancer: 10-year follow-up results of two randomised controlled trials. Lancet Oncol. 2013;14:1086–94.
doi: 10.1016/S1470-2045(13)70386-3
Whelan TJ, Pignol JP, Levine MN, Julian JA, MacKenzie R, Parpia S, Shelley W, Grimard L, Bowen J, Lukka H, Perera F, Fyles A, Schneider K, Gulavita S, Freeman C. Long-term results of hypofractionated radiation therapy for breast cancer. N Engl J Med. 2010;362(6):513–20. https://doi.org/10.1056/NEJMoa0906260 .
doi: 10.1056/NEJMoa0906260
pubmed: 20147717
Smith BD, Bellon JR, Blitzblau R, Freedman G, Haffty B, Hahn C, Halberg F, Hoffman K, Horst K, Moran J, Patton C, Perlmutter J, Warren L, Whelan T, Wright JL, Jagsi R. Radiation therapy for the whole breast: Executive summary of an American Society for Radiation Oncology (ASTRO) evidence-based guideline. Pract Radiat Oncol. 2018;8(3):145–52. https://doi.org/10.1016/j.prro.2018.01.012 .
doi: 10.1016/j.prro.2018.01.012
pubmed: 29545124
Joiner MC, Kogel A. Basic clinical radiobiology. 5th ed. Taylor & Francis; 2016.
Pasquier D, Hoelscher T, Schmutz J, Dische S, Mathieu D, Baumann M, Lartigau E. Hyperbaric oxygen therapy in the treatment of radio-induced lesions in normal tissues: a literature review. Radiother Oncol. 2004;72(1):1–13. https://doi.org/10.1016/j.radonc.2004.04.005 .
doi: 10.1016/j.radonc.2004.04.005
pubmed: 15236869
Delanian S, Lefaix JL. Current management for late normal tissue injury: radiation-induced fibrosis and necrosis. Semin Radiat Oncol. 2007;17(2):99–107. https://doi.org/10.1016/j.semradonc.2006.11.006 .
doi: 10.1016/j.semradonc.2006.11.006
pubmed: 17395040
Fleckenstein K, Gauter-Fleckenstein B, Jackson IL, Rabbani Z, Anscher M, Vujaskovic Z. Using biological markers to predict risk of radiation injury. Semin Radiat Oncol. 2007;17(2):89–98. https://doi.org/10.1016/j.semradonc.2006.11.004 .
doi: 10.1016/j.semradonc.2006.11.004
pubmed: 17395039
Fernandes TDF. Medicina hiperbárica. Acta Med Port. 2009;22(4):323–34.
pubmed: 19909659
Kang TS, Gorti GK, Quan SY, Ho M, Koch RJ. Effect of hyperbaric oxygen on the growth factor profile of fibroblasts. Arch Facial Plast Surg. 2004;6(1):31–5. https://doi.org/10.1001/archfaci.6.1.31 .
doi: 10.1001/archfaci.6.1.31
pubmed: 14732642
Oscarsson N, Ny L, Mölne J, Lind F, Ricksten SE, Seeman-Lodding H, Giglio D. Hyperbaric oxygen treatment reverses radiation induced pro-fibrotic and oxidative stress responses in a rat model. Free Radic Biol Med. 2017;103:248–55. https://doi.org/10.1016/j.freeradbiomed.2016.12.036 .
doi: 10.1016/j.freeradbiomed.2016.12.036
pubmed: 28034833
Bennett MH, Feldmeier J, Hampson NB, Smee R, Milross C. Hyperbaric oxygen therapy for late radiation tissue injury. Cochrane Database Syst Rev. 2016;4(4):CD005005. https://doi.org/10.1002/14651858.CD005005.pub4 .
doi: 10.1002/14651858.CD005005.pub4
pubmed: 27123955
Thom SR, Bhopale VM, Velazquez OC, Goldstein LJ, Thom LH, Buerk DG. Stem cell mobilization by hyperbaric oxygen. Am J Physiol Heart Circ Physiol. 2006;290(4):H1378–86. https://doi.org/10.1152/ajpheart.00888.2005 .
doi: 10.1152/ajpheart.00888.2005
pubmed: 16299259
Bennett MH, Feldmeier J, Hampson N, Smee R, Milross C. Hyperbaric oxygen therapy for late radiation tissue injury. Cochrane Database Syst Rev. 2005;20(3):CD005005. https://doi.org/10.1002/14651858.CD005005.pub2 .
doi: 10.1002/14651858.CD005005.pub2
Günther A, Küppers-Tiedt L, Schneider PM, Kunert I, Berrouschot J, Schneider D, Rossner S. Reduced infarct volume and differential effects on glial cell activation after hyperbaric oxygen treatment in rat permanent focal cerebral ischaemia. Eur J Neurosci. 2005;21(11):3189–94. https://doi.org/10.1111/j.1460-9568.2005.04151.x .
doi: 10.1111/j.1460-9568.2005.04151.x
pubmed: 15978027
Morabito C, Bosco G, Pilla R, Corona C, Mancinelli R, Yang Z, Camporesi EM, Fanò G, Mariggiò MA. Effect of pre-breathing oxygen at different depth on oxidative status and calcium concentration in lymphocytes of scuba divers. Acta Physiol (Oxf). 2011;202(1):69–78. https://doi.org/10.1111/j.1748-1716.2010.02247.x .
doi: 10.1111/j.1748-1716.2010.02247.x
Al-Waili NS, Butler GJ. Effects of hyperbaric oxygen on inflammatory response to wound and trauma: possible mechanism of action. ScientificWorldJournal. 2006;3(6):425–41. https://doi.org/10.1100/tsw.2006.78 .
doi: 10.1100/tsw.2006.78
Ercin CN, Yesilova Z, Korkmaz A, Ozcan A, Oktenli C, Uygun A. The effect of iNOS inhibitors and hyperbaric oxygen treatment in a rat model of experimental colitis. Dig Dis Sci. 2009;54(1):75–9. https://doi.org/10.1007/s10620-008-0498-1 .
doi: 10.1007/s10620-008-0498-1
pubmed: 18972208
Kendall AC, Whatmore JL, Harries LW, Winyard PG, Smerdon GR, Eggleton P. Changes in inflammatory gene expression induced by hyperbaric oxygen treatment in human endothelial cells under chronic wound conditions. Exp Cell Res. 2012;318(3):207–16. https://doi.org/10.1016/j.yexcr.2011.10.014 .
doi: 10.1016/j.yexcr.2011.10.014
pubmed: 22063471
Granowitz EV, Skulsky EJ, Benson RM, Wright J, Garb JL, Cohen ER, Smithline EC, Brown RB. Exposure to increased pressure or hyperbaric oxygen suppresses interferon-gamma secretion in whole blood cultures of healthy humans. Undersea Hyperb Med. 2002;29(3):216–25.
pubmed: 12670123
Moon YJ, Lee JY, Oh MS, Pak YK, Park KS, Oh TH, Yune TY. Inhibition of inflammation and oxidative stress by Angelica dahuricae radix extract decreases apoptotic cell death and improves functional recovery after spinal cord injury. J Neurosci Res. 2012;90(1):243–56. https://doi.org/10.1002/jnr.22734 .
doi: 10.1002/jnr.22734
pubmed: 21922518
Smit SG, Heyns CF. Management of radiation cystitis. Nat Rev Urol. 2010;7(4):206–14. https://doi.org/10.1038/nrurol.2010.23 .
doi: 10.1038/nrurol.2010.23
pubmed: 20212517
Droupy S. The therapeutic approach to different forms of cystitis: impact on public health. Urologia. 2017;84(Suppl 1):8–15. https://doi.org/10.5301/uj.5000262 .
doi: 10.5301/uj.5000262
pubmed: 28862726
Oliai C, Fisher B, Jani A, Wong M, Poli J, Brady LW, Komarnicky LT. Hyperbaric oxygen therapy for radiation-induced cystitis and proctitis. Int J Radiat Oncol Biol Phys. 2012;84(3):733–40. https://doi.org/10.1016/j.ijrobp.2011.12.056 .
doi: 10.1016/j.ijrobp.2011.12.056
pubmed: 22440041
Horan N, Cooper JS. Radiation cystitis and hyperbaric management. 2022 Jan. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022. Available from: https://www.ncbi.nlm.nih.gov/books/NBK430685/ .
Zhong QH, Liu ZZ, Yuan ZX, Ma TH, Huang XY, Wang HM, Chen DC, Wang JP, Wang L. Efficacy and complications of argon plasma coagulation for hemorrhagic chronic radiation proctitis. World J Gastroenterol. 2019;25(13):1618–27. https://doi.org/10.3748/wjg.v25.i13.1618 .
doi: 10.3748/wjg.v25.i13.1618
pubmed: 30983821
pmcid: 6452229
Denton A, Forbes A, Andreyev J, Maher EJ. Non surgical interventions for late radiation proctitis in patients who have received radical radiotherapy to the pelvis. Cochrane Database Syst Rev. 2002;1:CD003455. https://doi.org/10.1002/14651858.CD003455.pub2 .
doi: 10.1002/14651858.CD003455.pub2
Kochhar R, Sriram PV, Sharma SC, Goel RC, Patel F. Natural history of late radiation proctosigmoiditis treated with topical sucralfate suspension. Dig Dis Sci. 1999;44(5):973–8. https://doi.org/10.1023/a:1026612731210 .
doi: 10.1023/a:1026612731210
pubmed: 10235606
Vernia P, Fracasso PL, Casale V, Villotti G, Marcheggiano A, Stigliano V, Pinnaro P, Bagnardi V, Caprilli R. Topical butyrate for acute radiation proctitis: randomised, crossover trial. Lancet. 2000;356(9237):1232–5. https://doi.org/10.1016/s0140-6736(00)02787-2 .
doi: 10.1016/s0140-6736(00)02787-2
pubmed: 11072942
Karamanolis G, Psatha P, Triantafyllou K. Endoscopic treatments for chronic radiation proctitis. World J Gastrointest Endosc. 2013;5(7):308–12. https://doi.org/10.4253/wjge.v5.i7.308 .
doi: 10.4253/wjge.v5.i7.308
pubmed: 23858374
pmcid: 3711061
Sarin A, Safar B. Management of radiation proctitis. Gastroenterol Clin N Am. 2013;42(4):913–25. https://doi.org/10.1016/j.gtc.2013.08.004 .
doi: 10.1016/j.gtc.2013.08.004
Aarup-Kristensen S, Hansen CR, Forner L, Brink C, Eriksen JG, Johansen J. Osteoradionecrosis of the mandible after radiotherapy for head and neck cancer: risk factors and dose-volume correlations. Acta Oncol. 2019;58(10):1373–7. https://doi.org/10.1080/0284186X.2019.1643037 .
doi: 10.1080/0284186X.2019.1643037
pubmed: 31364903
Rogers SN, D’Souza JJ, Lowe D, Kanatas A. Longitudinal evaluation of health-related quality of life after osteoradionecrosis of the mandible. Br J Oral Maxillofac Surg. 2015;53(9):854–7. https://doi.org/10.1016/j.bjoms.2015.07.008 .
doi: 10.1016/j.bjoms.2015.07.008
pubmed: 26316016
Chronopoulos A, Zarra T, Ehrenfeld M, Otto S. Osteoradionecrosis of the jaws: definition, epidemiology, staging and clinical and radiological findings. A concise review. Int Dent J. 2018;68(1):22–30. https://doi.org/10.1111/idj.12318 .
doi: 10.1111/idj.12318
pubmed: 28649774
Dalsania R, Shah K, Stotsky-Himelfarb E, Hoffe S, Willingham F. American Society of Clinical Oncology Educational Book 41. 2021; p. 147–157.
Girvent M, Carlson GL, Anderson I, Shaffer J, Irving M, Scott NA. Intestinal failure after surgery for complicated radiation enteritis. Ann R Coll Surg Engl. 2000;82(3):198–201.
pubmed: 10858685
pmcid: 2503431
Lefevre JH, Amiot A, Joly F, Bretagnol F, Panis Y. Risk of recurrence after surgery for chronic radiation enteritis. Br J Surg. 2011;98(12):1792–7. https://doi.org/10.1002/bjs.7655 .
doi: 10.1002/bjs.7655
pubmed: 21928361
Alós M, Salvador M. Coste efectividad de la Terapia Hiperbárica en pacientes afectos de osteoradionecrosis de mandíbula y em los pacientes afectos de cistopatía hemorrágica y/o proctopatía hemorrágica radioinducidas. ISCIII: Informes de Evaluación de Tecnologías Sanitarias; 2009.
Clarke RE, Tenorio LM, Hussey JR, Toklu AS, Cone DL, Hinojosa JG, Desai SP, Dominguez Parra L, Rodrigues SD, Long RJ, Walker MB. Hyperbaric oxygen treatment of chronic refractory radiation proctitis: a randomized and controlled double-blind crossover trial with long-term follow-up. Int J Radiat Oncol Biol Phys. 2008;72(1):134–43. https://doi.org/10.1016/j.ijrobp.2007.12.048 .
doi: 10.1016/j.ijrobp.2007.12.048
pubmed: 18342453
Shaw RJ, Butterworth CJ, Silcocks P, Tesfaye BT, Bickerstaff M, Jackson R, Kanatas A, Nixon P, McCaul J, Praveen P, Lowe T, Blanco-Guzman M, Forner L, Brennan P, Fardy M, Parkin R, Smerdon G, Stephenson R, Cope T, Glover M. HOPON (Hyperbaric Oxygen for the Prevention of Osteoradionecrosis): a randomized controlled trial of hyperbaric oxygen to prevent osteoradionecrosis of the irradiated mandible after dentoalveolar surgery. Int J Radiat Oncol Biol Phys. 2019;104(3):530–9. https://doi.org/10.1016/j.ijrobp.2019.02.044 .
doi: 10.1016/j.ijrobp.2019.02.044
pubmed: 30851351
Forner LE, Dieleman FJ, Shaw RJ, Kanatas A, Butterworth CJ, Kjeller G, Alsner J, Overgaard J, Hillerup S, Hyldegaard O, Arnell P, von Buchwald C, Kaanders JHAM, Smeele LE, Specht L, Johansen J, Witjes MJH, Merkx MAW, Jansen EC. Hyperbaric oxygen treatment of mandibular osteoradionecrosis: combined data from the two randomized clinical trials DAHANCA-21 and NWHHT2009-1. Radiother Oncol. 2022;166:137–44. https://doi.org/10.1016/j.radonc.2021.11.021 .
doi: 10.1016/j.radonc.2021.11.021
pubmed: 34843843
Rubin P, Constine LS, Fajardo LF, Phillips TL, Wasserman TH, RTOG Late Effects Working Group. Overview. Late effects of normal tissues (LENT) scoring system. Int J Radiat Oncol Biol Phys. 1995;31(5):1041–2. https://doi.org/10.1016/0360-3016(95)00057-6 .
doi: 10.1016/0360-3016(95)00057-6
pubmed: 7713774
Routledge JA, Burns MP, Swindell R, Khoo VS, West CM, Davidson SE. Evaluation of the LENT-SOMA scales for the prospective assessment of treatment morbidity in cervical carcinoma. Int J Radiat Oncol Biol Phys. 2003;56(2):502–10. https://doi.org/10.1016/s0360-3016(02)04578-9 .
doi: 10.1016/s0360-3016(02)04578-9
pubmed: 12738327
avy JJ, Denekamp J, Letschert J, Littbrand B, Mornex F, Bernier J, Gonzales-Gonzales D, Horiot JC, Bolla M, Bartelink H, EORTC Late Effects Working Group. Late effects toxicity scoring: the SOMA scale. Radiother Oncol. 1995;35(1):11–5. https://doi.org/10.1016/0167-8140(95)97448-m .
doi: 10.1016/0167-8140(95)97448-m
Mathieu D, Marroni A, Kot J. Tenth European Consensus Conference on Hyperbaric Medicine: recommendations for accepted and non-accepted clinical indications and practice of hyperbaric oxygen treatment. Diving Hyperb Med. 2017;47(2):131–2. https://doi.org/10.28920/dhm47.1.24-32 .
doi: 10.28920/dhm47.1.24-32
pubmed: 28641327
pmcid: 6147755
Andren J, Bennett MH. An observational trial to establish the effect of hyperbaric oxygen treatment on pelvic late radiation tissue injury due to radiotherapy. Diving Hyperb Med. 2020;50(3):250–5. https://doi.org/10.28920/dhm50.3.250-255 .
doi: 10.28920/dhm50.3.250-255
pubmed: 32957127
pmcid: 7819726